Intravenous solutions (IV) are administered through the intravenous route in order to provide sugar, salt, and water directly into veins. IV solutions and electrolytes are used for fluid resuscitation, routine maintenance, replacement, and redistribution. Intravenous drugs, nutrition, and mixed solutions are modern therapy. The growth of this market is expected to grow on the account of the rising adoption of inorganic growth strategies such as collaborations and acquisitions by key players in order to expand their portfolio. For instance, in April 2015, Baxter International Inc. and France-based Laboratoire Aguettant SAS entered into a licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy.
The global intravenous solution market size was valued at US$ 8,372.0 million in 2019 and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027).
To Gain More Insights into the Intravenous Solutions Market, Browse Summary of the Research Report – https://www.coherentmarketinsights.com/market-insight/intravenous-solutions-market-1134
Intravenous Solution Market – Competitive Landscape
Key players operating in the global intravenous solution market include Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited.
“We Do Offer Sample of this report. Kindly go through the follow information in order to access the report.”
Note- This report sample includes:
– Brief Introduction to the research report.
– Table of Contents (Scope covered as a part of the study)
– Top players in the market
– Research framework (structure of the report)
– Research methodology adopted by Coherent Market Insights
Request A Sample Copy – Intravenous Solutions Market Report Click here: https://www.coherentmarketinsights.com/insight/request-sample/1134
Rising Launches and Regulatory Approvals for Intravenous Solution Injection is projected to Drive Growth of the Global Intravenous Solution Market
Rising approvals for intravenous solution injections from regulatory authorities are projected to drive the global intravenous solution market growth over the forecast period. For instance, in 2015, B. Braun Medical Inc, a subsidiary of B.Braun, operating in infusion therapy and pain management, announced the U.S. FDA approval for its 70% Dextrose for Injection in a 2L flexible container. 70% Dextrose for Injection is an intravenous solution indicated as a source of calories and fluid replenishment.
Moreover, launches of new intravenous solution injections for the treatment of various chronic diseases such as dehydration, gastrointestinal diseases are projected to drive the intravenous solution market growth over the forecast period. For instance, in 2017, Fresenius Kabi USA, LLC, offers medicines and technologies for infusion, transfusion, and clinical nutrition launched of Vecuronium Bromide for Injection in the U.S. The drug is indicated for maintenance of neuromuscular blockade and paralysis.
Intravenous Solution Market – Restraints
Increasing FDA recalls of IV products is the major factor hampering market growth. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company’s NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1134
Intravenous Solution Market- Regional Insights
Based on the region, the global intravenous solution market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe is expected to hold a dominant position in the global intravenous solution market over the forecast period, and this can be attributed to increasing introduction of parenteral (intravenous) nutrition (PN) products. For instance, in 2016, Baxter International Inc., a global leader in PN therapy, launched NUMETA G13E 300 mL in Europe. NUMETA G13E is the only ready-to-use parenteral (intravenous) nutrition (PN) product for preterm infants (less than 37 weeks gestation age).
At the same time, Asia Pacific is expected to experience a rapid growth in the intravenous solution market, owing to the rising introduction of technologically advanced intravenous solutions by key players. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion & pharmaceuticals, launched two intravenous IV products: Discport and Lifeport in the India drug market. The product is considered a smart intravenous infusion, which encompasses the latest technology that reduces the chances of any infection.
Detailed Segmentation:
- Global Intravenous Solution Market , By Solution Type:
- Saline
- Normal Saline (0.9% NaCl)
- Hypertonic Saline
- Dextran
- Lactated Ringer’s
- Amino Acid
- Vitamins & Minerals
- Heparin and Trace Elements
- Mixed Solutions
- Saline
- Global Intravenous Solution Market , By Bag Type:
- Large Volume Bags (greater than 250ml)
- Small Volume Bags (less than 250ml)
- Global Intravenous Solution Market , By Application:
- Basic IV Solution
- Nutritional IV Solution
- Blood IV Solution
- Drug IV Solution
- Irrigation IV Solution
- Global Intravenous Solution Market , By End-user:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
- Global Intravenous Solution Market , By Region:
- North America
- By Country:
- U.S.
- Canada
- By Solution Type :
- Saline
- Normal Saline (0.9% NaCl)
- Hypertonic Saline
- Dextran
- Lactated Ringer’s
- Amino Acid
- Vitamins & Minerals
- Heparin and Trace Elements
- Mixed Solutions
- Saline
- By Bag Type:
- Large Volume Bags (greater than 250ml)
- Small Volume Bags (less than 250ml)
- By Application:
- Basic IV Solution
- Nutritional IV Solution
- Blood IV Solution
- Drug IV Solution
- Irrigation IV Solution
- By End-user:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
- By Country:
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Solution Type :
- By Bag Type:
- By Application:
- By End-user:
- By Country:
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Solution Type :
- By Bag Type:
- By Application:
- By End-user:
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Solution Type :
- By Bag Type:
- By Application:
- By End-user:
- By Country:
- Middle East
- By Country/Region:
- GCC
- Israel
- Rest of Middle East
- By Solution Type :
- By Bag Type:
- By Application:
- By End-user:
- By Country/Region:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Solution Type :
- By Bag Type:
- By Application:
- By End-user:
- By Country/Region:
- North America
Browse Press Release: https://bit.ly/3674HzE
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837